Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.

Shimada K, Yamaguchi M, Atsuta Y, Matsue K, Sato K, Kusumoto S, Nagai H, Takizawa J, Fukuhara N, Nagafuji K, Miyazaki K, Ohtsuka E, Okamoto M, Sugita Y, Uchida T, Kayukawa S, Wake A, Ennishi D, Kondo Y, Izumi T, Kin Y, Tsukasaki K, Hashimoto D, Yuge M, Yanagisawa A, Kuwatsuka Y, Shimada S, Masaki Y, Niitsu N, Kiyoi H, Suzuki R, Tokunaga T, Nakamura S, Kinoshita T

Open source

DOI: 10.1016/s1470-2045(20)30059-0
Published: 2020 Apr
Container: The Lancet. Oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-20-30059-0,
  title = {Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.},
  author = {Shimada K and Yamaguchi M and Atsuta Y and Matsue K and Sato K and Kusumoto S and Nagai H and Takizawa J and Fukuhara N and Nagafuji K and Miyazaki K and Ohtsuka E and Okamoto M and Sugita Y and Uchida T and Kayukawa S and Wake A and Ennishi D and Kondo Y and Izumi T and Kin Y and Tsukasaki K and Hashimoto D and Yuge M and Yanagisawa A and Kuwatsuka Y and Shimada S and Masaki Y and Niitsu N and Kiyoi H and Suzuki R and Tokunaga T and Nakamura S and Kinoshita T},
  year = {2020},
  journal = {The Lancet. Oncology},
  doi = {10.1016/s1470-2045(20)30059-0},
  url = {https://doi.org/10.1016/s1470-2045(20)30059-0}
}

RIS

TY  - JOUR
TI  - Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
AU  - Shimada K
AU  - Yamaguchi M
AU  - Atsuta Y
AU  - Matsue K
AU  - Sato K
AU  - Kusumoto S
AU  - Nagai H
AU  - Takizawa J
AU  - Fukuhara N
AU  - Nagafuji K
AU  - Miyazaki K
AU  - Ohtsuka E
AU  - Okamoto M
AU  - Sugita Y
AU  - Uchida T
AU  - Kayukawa S
AU  - Wake A
AU  - Ennishi D
AU  - Kondo Y
AU  - Izumi T
AU  - Kin Y
AU  - Tsukasaki K
AU  - Hashimoto D
AU  - Yuge M
AU  - Yanagisawa A
AU  - Kuwatsuka Y
AU  - Shimada S
AU  - Masaki Y
AU  - Niitsu N
AU  - Kiyoi H
AU  - Suzuki R
AU  - Tokunaga T
AU  - Nakamura S
AU  - Kinoshita T
PY  - 2020
JO  - The Lancet. Oncology
DO  - 10.1016/s1470-2045(20)30059-0
UR  - https://doi.org/10.1016/s1470-2045(20)30059-0
ER  -

APA

K, S., M, Y., Y, A., K, M., K, S., S, K., H, N., J, T., N, F., K, N., K, M., E, O., M, O., Y, S., T, U., S, K., A, W., D, E., Y, K., T, I., Y, K., K, T., D, H., M, Y., A, Y., Y, K., S, S., Y, M., N, N., H, K., R, S., T, T., S, N., & T, K. (2020). Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(20)30059-0

Source records

pubmed · retrieved 2026-09-26T22:14:03.745Z